Physician

David Alexandre Chetrit, MD

According to 2025 Medicare claims, David Chetrit, MD (NPI: 1285155010) practices rheumatology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is STRAND PHYSICIAN SPECIALISTS, PA (NPI: 1194707901; TIN: 570963173) and primary practice location at 29572-4612. Chetrit is affiliated with the Aledade 153 SC MSSP Enhanced (ACO ID: A5356), participating under the MSSP model.

Chetrit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 827 traditional Medicare patients, billed 313,331 HCPCS/CPT codes, and received $3,273,395 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,616 prescription claims across 571 beneficiaries totaling $3,206,924 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 142 records totaling $2,285. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $1,572 to $3,206,924. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2022 Medicare payment: $374,938 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,492,895 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,273,395 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202232329,945$374,938
2023755216,033$2,492,895
2024827313,331$3,273,395

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2017 Drug cost: $1,572 (USD; Tot_Drug_Cst)2018 Drug cost: $27,885 (USD; Tot_Drug_Cst)2019 Drug cost: $8,695 (USD; Tot_Drug_Cst)2020 Drug cost: $20,366 (USD; Tot_Drug_Cst)2021 Drug cost: $54,444 (USD; Tot_Drug_Cst)2022 Drug cost: $177,397 (USD; Tot_Drug_Cst)2023 Drug cost: $1,903,715 (USD; Tot_Drug_Cst)2024 Drug cost: $3,206,924 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172676$1,572
201857258$27,885
201950217$8,695
2020100418$20,366
20211561$54,444
2022139279$177,397
20234412,597$1,903,715
20245713,616$3,206,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more426980$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's326528$12
36415Insertion of needle into vein for collection of blood sample390678$9
86140Measurement c-reactive protein for detection of infection or inflammation313543$5
85652Red blood cell sedimentation rate, to detect inflammation, automated316545$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1033,926$990,955
RinvoqUpadacitinib833,570$750,229
Orencia ClickjectAbatacept521,680$334,066
Skyrizi PenRisankizumab-Rzaa12896$248,144
Enbrel SureclickEtanercept11644$163,135

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.142$2,285ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Alexandre Chetrit, MD?

Tedicare shows public-source Medicare data for David Alexandre Chetrit, MD (NPI 1285155010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Alexandre Chetrit, MD have ACO affiliation data?

David Alexandre Chetrit, MD is shown with ACO affiliation data for Aledade 153 SC MSSP Enhanced (MSSP, ACO ID A5356).

What billing organization is linked to David Alexandre Chetrit, MD?

David Alexandre Chetrit, MD is linked to STRAND PHYSICIAN SPECIALISTS, PA (billing NPI 1194707901) in the available physician profile data.

Does David Alexandre Chetrit, MD have Open Payments data?

David Alexandre Chetrit, MD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.